|Bid||2.3200 x 38500|
|Ask||2.3300 x 36900|
|Day's range||2.2900 - 2.4150|
|52-week range||1.0700 - 6.4500|
|Beta (5Y monthly)||1.17|
|PE ratio (TTM)||N/A|
|Earnings date||29 Nov 2021 - 03 Dec 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Today's gains probably shouldn't be too surprising, however, coming as they do on the back of positive comments from the CEO of MJBiz, a cannabis industry news site, yesterday evening. Speaking at MJBizCon 2021 in Las Vegas, company CEO Chris Walsh predicted that whatever happens in Congress, 2022 will see at least four more states flip to recreational marijuana legalization -- and perhaps as many as seven. Additionally, Walsh points out that Idaho and Nebraska are in line to legalize marijuana for medicinal purposes.
Valens trades at a discount compared to other marijuana stocks, but that could change as its shares become available on one of the top North American exchanges.
Marijuana stocks are hopping in Tuesday morning trading. Shares of Green Thumb Industries (OTC: GTBIF) are up 2.3% at 10:15 a.m. EDT, Canopy Growth (NASDAQ: CGC) stock up 4.5%, and OrganiGram Holdings (NASDAQ: OGI) doing best of all -- up 5.5%. At the state level, on the other hand, marijuana legalization continues to march straight ahead.